Rapid Micro Biosystems (RPID) Change in Account Payables (2020 - 2026)
Rapid Micro Biosystems (RPID) posted Change in Account Payables of $530000.0 for Q1 2026, down 3.46% sequentially from $549000.0 in Q4 2025, and up 430.0% YoY from $100000.0 in Q1 2025.
Rapid Micro Biosystems (RPID) Change in Account Payables (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems has reported Change in Account Payables for 7 years, with the latest figure at $530000.0 in Q1 2026.
- Quarterly Change in Account Payables rose 430.0% year-over-year to $530000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (up 38.0% YoY) and the FY2025 annual result came in at $1.6 million, up 184.7% from the prior year.
- Change in Account Payables eased to $530000.0 in Q1 2026 per RPID's latest filing, from $549000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $1.9 million in Q3 2023 and troughed at -$4.1 million in Q1 2023.
- A 5-year average of $42411.8 and a median of $205000.0 in 2024 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2022 and 2024: Change in Account Payables sank 1037.5% in 2022, then soared 1219.48% in 2024.
- Over 5 years, Change in Account Payables stood at $1.8 million in 2022, then slumped by 173.79% to -$1.3 million in 2023, then surged by 115.79% to $205000.0 in 2024, then soared by 167.8% to $549000.0 in 2025, then fell by 3.46% to $530000.0 in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered $530000.0, $549000.0, and $251000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 71.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -200.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 4.30 Mn |
| 10 | Rapid Micro Biosystems | 80.26 Mn | 60.49 Mn | 1.21 Mn | 408,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 408,000.00 |
| Jun 30, 2026 | 408,000.00 |
| Mar 31, 2026 | 530,000.00 |
| Mar 31, 2026 | 530,000.00 |
| Dec 31, 2025 | 549,000.00 |
| Dec 31, 2025 | 549,000.00 |
| Sep 30, 2025 | 251,000.00 |
| Sep 30, 2025 | 251,000.00 |
| Jun 30, 2025 | 700,000.00 |
| Jun 30, 2025 | 700,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 205,000.00 |
| Dec 31, 2024 | 205,000.00 |
| Sep 30, 2024 | 150,000.00 |
| Sep 30, 2024 | 150,000.00 |
| Jun 30, 2024 | 1.02 Mn |
| Jun 30, 2024 | 1.02 Mn |
| Mar 31, 2024 | -809,000.00 |
| Mar 31, 2024 | -809,000.00 |